33 results on '"Infantino R"'
Search Results
2. Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice
- Author
-
Palazzo E, Boccella S, Marabese I, Perrone M, Belardo C, Iannotta M, Scuteri D, De Dominicis E, Pagano M, Infantino R, Bagetta G, Maione S., Palazzo, E, Boccella, S, Marabese, I, Perrone, M, Belardo, C, Iannotta, M, Scuteri, D, De Dominicis, E, Pagano, M, Infantino, R, Bagetta, G, and Maione, S.
- Published
- 2022
3. Short term effect of cigarette smoke on exhaled volatile organic compounds profile analyzed by an eNose.
- Author
-
Dragonieri, S, primary, Buonamico, E, additional, Caringella, A, additional, Infantino, R, additional, Intiglietta, P, additional, Valerio, V N, additional, Partuno, M, additional, Labate, L, additional, and Carpagnano, G E, additional
- Published
- 2022
- Full Text
- View/download PDF
4. 2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors
- Author
-
Boccella S, Guida F, Iannotta M, Iannotti FA, Infantino R, Ricciardi F, Cristiano C, Vitale RM, Amodeo P, Marabese I, Belardo C, de Novellis V, Paino S, Palazzo E, Calignano A, Di Marzo V, Maione S, and Luongo L.
- Subjects
histamine autoreceptors ,Pain ,2-Pentadecyl-2-oxazoline - Abstract
Neuropathic pain (NP) remains an untreatable disease due to the complex pathophysiology that involves the whole pain neuraxis including the forebrain. Sensory dysfunctions such as allodynia and hyperalgesia are only part of the symptoms associated with neuropathic pain that extend to memory and affectivity deficits. The development of multi-target molecules might be a promising therapeutic strategy against the symptoms associated with NP. 2-pentadecyl-2-oxazoline (PEA-OXA) is a plant-derived agent, which has shown effectiveness against chronic pain and associated neuropsychiatric disorders. The molecular mechanisms by which PEA-OXA exerts its effects are, however, only partially known. In the current study, we show that PEA-OXA, besides being an alpha2 adrenergic receptor antagonist, also acts as a modulator at histamine H3 receptors, and report data on its effects on sensory, affective and cognitive symptoms associated with the spared nerve injury (SNI) model of neuropathic pain in mice. Treatment for 14 days with PEA-OXA after the onset of the symptoms associated with neuropathic pain resulted in the following effects: (i) allodynia was decreased; (ii) affective/cognitive impairment associated with SNI (depression, spatial, and working memories) was counteracted; (iii) long-term potentiation in vivo in the lateral entorhinal cortex-dentate gyrus (perforant pathway, LPP) was ameliorated, (iv) hippocampal glutamate, GABA, histamine, norepinephrine and dopamine level alterations after peripheral nerve injury were reversed, (v) expression level of the TH positive neurons in the Locus Coeruleus were normalized. Thus, a 16-day treatment with PEA-OXA alleviates the sensory, emotional, cognitive, electrophysiological and neurochemical alterations associated with SNI-induced neuropathic pain.
- Published
- 2021
5. Oral Cannabidiol Prevents Allodynia and Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury
- Author
-
Belardo C, Iannotta M, Boccella S, Rubino RC, Ricciardi F, Infantino R, Pieretti G, Stella L, Paino S, Marabese I, Maisto R, Luongo L, Maione S, Guida F., Belardo, C, Iannotta, M, Boccella, S, Rubino, Rc, Ricciardi, F, Infantino, R, Pieretti, G, Stella, L, Paino, S, Marabese, I, Maisto, R, Luongo, L, Maione, S, and Guida, F.
- Published
- 2019
6. The Function of Carbonic Anhydrase in Crustacean Gills
- Author
-
Burnett, L. E., Dunn, T. N., Infantino, R. L., Jr., Gilles, Raymond, editor, and Gilles-Baillien, Michelle, editor
- Published
- 1985
- Full Text
- View/download PDF
7. Proprietà spettrali per una classe di operatori ellittici
- Author
-
Infantino, R., Matarasso, S., and Troisi, M.
- Published
- 1979
- Full Text
- View/download PDF
8. GPs' role in reducing the risk of bronchospasm in asthma patients undergoing general anesthesia and/or intravascular administration of radiographic contrast media.
- Author
-
Liccardi G, Infantino A, Paggiaro P, Fabbri LM, Salzillo A, Infantino R, and D'Amato G
- Published
- 2011
9. Cannabidiol in traumatic brain injury
- Author
-
Enza Palazzo, Monica Iannotta, Carmela Belardo, Rosmara Infantino, Flavia Ricciardi, Serena Boccella, Francesca Guida, Livio Luongo, Sabatino Maione, Palazzo, E., Iannotta, M., Belardo, C., Infantino, R., Ricciardi, F., Boccella, S.,Guida, F., Luongo, L., Maione, S., Palazzo, Enza, Iannotta, Monica, Belardo, Carmela, Infantina, Rosmara, Ricciardi, Flavia, Boccella, Serena, Guida, Francesca, Luongo, Livio, and Maione, Sabatino
- Subjects
Traumatic brain injury ,Endocannabinoid system ,Neuroinflammation ,Post-traumatic stress disorder ,Cannabidiol ,Phytocannabinoid - Abstract
Following injury, the endocannabinoid system is activated in the brain suggesting a strategic role in the self-repair mechanisms. Indeed endocannabinoid system manipulation ameliorates traumatic brain injury (TBI) symptoms. Cannabidiol (CBD), together with △9-tetrahydrocannabinol (THC), is the main phytocannabinoid extracted from the plant Cannabis sativa, and it plays anti-inflammatory, antioxidant, neuroprotective, anticonvulsant, hypnotic, and antiemetic effects and has proven to be useful in neuropsychiatric, neurodegenerative, post-traumatic stress, and ischemic disorders. Unlike THC, CBD is not psychoactive and enhances the beneficial and reduces the side effects of THC. CBD has negligible action on cannabinoid receptors and modulates the endocannabinoid system throughout the inhibition of endocannabinoid degradation and reuptake. It also stimulates serotonin 1A (5-HT1A), adenosine 2A (A2A), transient receptor potential vanilloid subtype 1 (TRPV1), and nuclear peroxisome proliferator-activated receptor γ (PPARγ). We collect in this chapter all the preclinical and clinical evidence on the beneficial effects of CBD in the TBI considering it important for two main reasons: the lack of effective therapy for the TBI and the good tolerability of the CBD.
- Published
- 2022
10. Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions
- Author
-
Antonio Calignano, Serena Boccella, Monica Iannotta, Carmela Belardo, Sabatino Maione, Rosmara Infantino, Francesca Guida, Vincenzo Di Marzo, Flavia Ricciardi, Claudia Cristiano, Livio Luongo, Fabio Del Bello, Fabio Arturo Iannotti, Mario Giannella, Boccella, S., Iannotta, M., Cristiano, C., Iannotti, F. A., Bello, F. D., Guida, F., Belardo, C., Infantino, R., Ricciardi, F., Giannella, M., Calignano, A., Di Marzo, V., Maione, S., and Luongo, L.
- Subjects
0301 basic medicine ,Traumatic brain injury ,Morris water navigation task ,Brain damage ,Open field ,03 medical and health sciences ,0302 clinical medicine ,Dopamine ,Medicine ,Premovement neuronal activity ,pain ,Pharmacology (medical) ,Prefrontal cortex ,Neuroinflammation ,Original Research ,electrophyiology ,Pharmacology ,business.industry ,traumatic brain injury ,lcsh:RM1-950 ,food and beverages ,plant metabolite ,medicine.disease ,behaviour ,lcsh:Therapeutics. Pharmacology ,030104 developmental biology ,030220 oncology & carcinogenesis ,medicine.symptom ,business ,Neuroscience ,medicine.drug - Abstract
Traumatic brain injury (TBI) represents an important public health problem and is followed by neuroinflammation and neurological dysfunctions. It has been suggested that brain trauma is often associated to deep behavioral alterations and chronic pain-like syndrome. Despite inducing minimal brain damage, mild TBI (mTBI) leads to persistent behavioral changes, including anxiety, depression, social interaction impairment, and aggressiveness. The clinical management of these symptoms is still unsatisfactory and new pharmacological treatments are needed, especially for the aggressiveness and depression. In a mouse model of mTBI, we investigated the effect of 2-Pentadecyl-2-Oxazoline (PEA-OXA), a natural compound, that is a secondary metabolite, found in green and roasted coffee beans, on both the pain perception, and neuropsychiatric dysfunctions. We found that the compound acts as a α2 adrenergic antagonist and this mechanism is here described for the first time. Mild TBI mice, starting from 14-d post-trauma, developed anxious and aggressive behavior, whilst depressive-like behavior and impaired social interactions were observed from the 60th d onward. PEA-OXA normalized all the behavioral changes investigated. We also investigated the memory impairments through Morris Water Maze (MWM) test. Both sham and mTBI mice treated with PEA-OXA showed amelioration in the reversal task of the MWM. Nevertheless, the main symptom of the long-term mTBI is represented by the depressive-like behavior, which was completely reversed by PEA-OXA repeated administration. In humans, mTBI-induced depression precedes the appearance of dementias and is characterized by a massive deficit of GABAergic transmission in the cortices. We found that PEA-OXA normalized the GABA changes in the prefrontal cortex. In order to prove the α2-mediated effect of the PEA-OXA we have performed open field test in naïve animals by microinjecting into the medial prefrontal cortex the dexomedetomidine, a selective α2 agonist with or without PEA-OXA co-injection. We found that PEA-OXA antagonized the α2 agonist effect on the locomotor activity. Moreover, PEA-OXA microinjection into the medial prefrontal cortex induced an enhancement of dopamine release. Collectively, these data suggest that this natural compound, through its multi-target activity is able to: i) ameliorate behavioral alterations (i.e. depression), ii) selectively normalize cortical GABA levels, iii) rescue the impaired neuronal activity in the prefrontal cortex.
- Published
- 2020
11. Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain
- Author
-
Francesca Guida, Serena Boccella, Livio Luongo, Vito de Novellis, Ida Marabese, Flavia Ricciardi, Federica Formato, Enza Palazzo, Danilo De Gregorio, Rosmara Infantino, Sabatino Maione, Carmela Belardo, Monica Iannotta, Guida, Francesca, De Gregorio Danilo, Palazzo, Enza, Ricciardi, Flavia, Boccella, Serena, Belardo, Carmela, Iannotta, Monica, Infantino, Rosmara, Marabese, Ida, Formato, Federica, Luongo, Livio, DE NOVELLIS, Vito, Maione, Sabatino, Guida, F., De Gregorio, D., Palazzo, E., Ricciardi, F., Boccella, S., Belardo, C., Iannotta, M., Infantino, R., Formato, F., Marabese, I., Luongo, L., de Novellis, V., and Maione, S.
- Subjects
Pain Threshold ,SNi ,Review ,Disease ,Somatosensory system ,Neuropathic pain ,Catalysis ,Inorganic Chemistry ,lcsh:Chemistry ,immune cells ,Peripheral Nerve Injuries ,medicine ,Animals ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,lcsh:QH301-705.5 ,Spectroscopy ,Behavior ,Immune cell ,Behavior, Animal ,business.industry ,Organic Chemistry ,Immune cells ,Spared nerve injury ,Brain ,General Medicine ,Nerve injury ,medicine.disease ,Electrophysiological Phenomena ,Computer Science Applications ,Electrophysiology ,Disease Models, Animal ,Allodynia ,Mood disorders ,lcsh:Biology (General) ,lcsh:QD1-999 ,Hyperalgesia ,Neuralgia ,medicine.symptom ,business ,Neuroscience - Abstract
Neuropathic pain is a pathological condition induced by a lesion or disease affecting the somatosensory system, with symptoms like allodynia and hyperalgesia. It has a multifaceted pathogenesis as it implicates several molecular signaling pathways involving peripheral and central nervous systems. Affective and cognitive dysfunctions have been reported as comorbidities of neuropathic pain states, supporting the notion that pain and mood disorders share some common pathogenetic mechanisms. The understanding of these pathophysiological mechanisms requires the development of animal models mimicking, as far as possible, clinical neuropathic pain symptoms. Among them, the Spared Nerve Injury (SNI) model has been largely characterized in terms of behavioral and functional alterations. This model is associated with changes in neuronal firing activity at spinal and supraspinal levels, and induces late neuropsychiatric disorders (such as anxious-like and depressive-like behaviors, and cognitive impairments) comparable to an advanced phase of neuropathy. The goal of this review is to summarize current findings in preclinical research, employing the SNI model as a tool for identifying pathophysiological mechanisms of neuropathic pain and testing pharmacological agent.
- Published
- 2020
12. N-palmitoyl-D-glucosamine, A Natural Monosaccharide-Based Glycolipid, Inhibits TLR4 and Prevents LPS-Induced Inflammation and Neuropathic Pain in Mice
- Author
-
Iacopo Panarese, Livio Luongo, Serena Boccella, Rosa Maria Vitale, Flavia Ricciardi, Monica Iannotta, Luigia Cristino, Carmela Belardo, Francesca Guida, Franca Ferraraccio, Lea Tunisi, Maria Consiglia Trotta, Rosa Maisto, Benito Fabio Mirto, Michele D'Amico, Pietro Amodeo, Fabio Arturo Iannotti, Sabatino Maione, Rosmara Infantino, Vincenzo Di Marzo, Iannotta, M., Belardo, C., Trotta, M. C., Iannotti, F. A., Vitale, R. M., Maisto, R., Boccella, S., Infantino, R., Ricciardi, F., Mirto, B. F., Ferraraccio, F., Panarese, I., Amodeo, P., Tunisi, L., Cristino, L., D'Amico, M., Di Marzo, V., Luongo, L., Maione, S., and Guida, F.
- Subjects
Lipopolysaccharides ,Male ,Models, Molecular ,peripheral neuropathy ,Protein Conformation ,Anti-Inflammatory Agents ,Drug Evaluation, Preclinical ,Pharmacology ,lcsh:Chemistry ,Lipid A ,Mice ,Random Allocation ,chemistry.chemical_compound ,Glucosamine ,TLR4 ,Receptor ,lcsh:QH301-705.5 ,TRPA1 Cation Channel ,Spectroscopy ,Analgesics ,Chemistry ,Nociceptors ,N-palmitoyl-D-glucosamine ,General Medicine ,Sciatic Nerve ,Computer Science Applications ,Hyperalgesia ,lipids (amino acids, peptides, and proteins) ,medicine.symptom ,LPS ,Lymphocyte Antigen 96 ,Inflammation ,Article ,Catalysis ,Inorganic Chemistry ,Downregulation and upregulation ,In vivo ,medicine ,Animals ,Humans ,Calcium Signaling ,Physical and Theoretical Chemistry ,Cytokine ,Molecular Biology ,cytokines ,inflammation ,mouse ,Keratitis ,Organic Chemistry ,Nerve injury ,Toll-Like Receptor 4 ,MicroRNAs ,HEK293 Cells ,RAW 264.7 Cells ,lcsh:Biology (General) ,lcsh:QD1-999 ,Neuralgia ,Inflamma-tion ,Glycolipids - Abstract
Toll-like receptors (TLRs) are key receptors through which infectious and non-infectious challenges act with consequent activation of the inflammatory cascade that plays a critical function in various acute and chronic diseases, behaving as amplification and chronicization factors of the inflammatory response. Previous studies have shown that synthetic analogues of lipid A based on glucosamine with few chains of unsaturated and saturated fatty acids, bind MD-2 and inhibit TLR4 receptors. These synthetic compounds showed antagonistic activity against TLR4 activation in vitro by LPS, but little or no activity in vivo. This study aimed to show the potential use of N-palmitoyl-D-glucosamine (PGA), a bacterial molecule with structural similarity to the lipid A component of LPS, which could be useful for preventing LPS-induced tissue damage or even peripheral neuropathies. Molecular docking and molecular dynamics simulations showed that PGA stably binds MD-2 with a MD-2/(PGA)3 stoichiometry. Treatment with PGA resulted in the following effects: (i) it prevented the NF-kB activation in LPS stimulated RAW264.7 cells, (ii) it decreased LPS-induced keratitis and corneal pro-inflammatory cytokines, whilst increasing anti-inflammatory cytokines, (iii) it normalized LPS-induced miR-20a-5p and miR-106a-5p upregulation and increased miR-27a-3p levels in the inflamed corneas, (iv) it decreased allodynia in peripheral neuropathy induced by oxaliplatin or formalin, but not following spared nerve injury of the sciatic nerve (SNI), (v) it prevented the formalin- or oxaliplatin-induced myelino-axonal degeneration of sciatic nerve. SIGNIFICANCE STATEMENT We report that PGA acts as a TLR4 antagonist and this may be the basis of its potent anti-inflammatory activity. Being unique because of its potency and stability, as compared to other similar congeners, PGA can represent a tool for the optimization of new TLR4 modulating drugs directed against the cytokine storm and the chronization of inflammation.
- Published
- 2021
- Full Text
- View/download PDF
13. Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI.
- Author
-
Guida F, Iannotta M, Lauritano A, Infantino R, Salviati E, Verde R, Luongo L, Sommella EM, Iannotti FA, Campiglia P, Maione S, Di Marzo V, and Piscitelli F
- Subjects
- Animals, Mice, Serotonin metabolism, Biomarkers metabolism, Male, Brain Concussion metabolism, Disease Models, Animal, Mice, Inbred C57BL, Brain metabolism, Amyloid beta-Protein Precursor genetics, Amyloid beta-Protein Precursor metabolism, Prodromal Symptoms, Amyloid beta-Peptides metabolism, Alzheimer Disease metabolism, Alzheimer Disease genetics, Mice, Transgenic, Endocannabinoids metabolism, Cognitive Dysfunction metabolism
- Abstract
Background: Despite extensive studies on the neurobiological correlates of traumatic brain injury (TBI), little is known about its molecular determinants on long-term consequences, such as dementia and Alzheimer's disease (AD)., Methods: Here, we carried out behavioural studies and an extensive biomolecular analysis, including inflammatory cytokines, gene expression and the combination of LC-HRMS and MALDI-MS Imaging to elucidate the targeted metabolomics and lipidomics spatiotemporal alterations of brains from wild-type and APP-SWE mice, a genetic model of AD, at the presymptomatic stage, subjected to mild TBI., Results: We found that brain injury does not affect cognitive performance in APP-SWE mice. However, we detected an increase of key hallmarks of AD, including Aβ
1-42 levels and BACE1 expression, in the cortices of traumatized transgenic mice. Moreover, significant changes in the expanded endocannabinoid (eCB) system, or endocannabinoidome (eCBome), occurred, including increased levels of the endocannabinoid 2-AG in APP-SWE mice in both the cortex and hippocampus, and N-acylserotonins, detected for the first time in the brain. The gene expression of enzymes for the biosynthesis and inactivation of eCBs and eCB-like mediators, and some of their main molecular targets, also underwent significant changes. We also identified the formation of heteromers between cannabinoid 1 (CB1 ) and serotonergic 2A (5HT2A ) receptors, whose levels increased in the cortex of APP-SWE mTBI mice, possibly contributing to the exacerbated pathophysiology of AD induced by the trauma., Conclusions: Mild TBI induces biochemical changes in AD genetically predisposed mice and the eCBome may play a role in the pathogenetic link between brain injury and neurodegenerative disorders also by interacting with the serotonergic system., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
14. Spinal neuronal activity and neuroinflammatory component in a mouse model of CFA-induced vestibulodynia.
- Author
-
Boccella S, Perrone M, Fusco A, Bonsale R, Infantino R, Nuzzo S, Pecoraro G, Ricciardi F, Maria Morace A, Petrillo G, Leone I, Franzese M, de Novellis V, Guida F, Salvatore M, Maione S, and Luongo L
- Subjects
- Animals, Mice, Female, Neuroinflammatory Diseases physiopathology, Gabapentin pharmacology, Amitriptyline pharmacology, Depression physiopathology, Depression metabolism, Mice, Inbred C57BL, Disease Models, Animal, Spinal Cord metabolism, Spinal Cord physiopathology, Freund's Adjuvant, Hyperalgesia physiopathology, Hyperalgesia metabolism, Vulvodynia physiopathology, Vulvodynia metabolism, Microglia metabolism, Neurons metabolism
- Abstract
Vestibulodynia is a complex pain disorder characterized by chronic discomfort in the vulvar region, often accompanied by tactile allodynia and spontaneous pain. In patients a depressive behaviour is also observed. In this study, we have used a model of vestibulodynia induced by complete Freund's adjuvant (CFA) focusing our investigation on the spinal cord neurons and microglia. We investigated tactile allodynia, spontaneous pain, and depressive-like behavior as key behavioral markers of vestibulodynia. In addition, we conducted in vivo electrophysiological recordings to provide, for the first time to our knowledge, the characterization of the spinal sacral neuronal activity in the L6-S1 dorsal horn of the spinal cord. Furthermore, we examined microglia activation in the L6-S1 dorsal horn using immunofluorescence, unveiling hypertrophic phenotypes indicative of neuroinflammation in the spinal cord. This represents a novel insight into the role of microglia in vestibulodynia pathology. To address the therapeutic aspect, we employed pharmacological interventions using GABApentin, amitriptyline, and PeaPol. Remarkably, all three drugs, also used in clinic, showed efficacy in alleviating tactile allodynia and depressive-like behavior. Concurrently, we also observed a normalization of the altered neuronal firing and a reduction of microglia hypertrophic phenotypes. In conclusion, our study provides a comprehensive understanding of the CFA-induced model of vestibulodynia, encompassing behavioral, neurophysiological and neuroinflammatory aspects. These data pave the way to investigate spinal cord first pain plasticity in vestibulodynia., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. PEA-OXA restores cognitive impairments associated with vitamin D deficiency-dependent alterations of the gut microbiota.
- Author
-
Guida F, Iannotta M, Perrone M, Infantino R, Giorgini G, Fusco A, Marabese I, Manzo I, Belardo C, Di Martino E, Pagano S, Boccella S, Silvestri C, Luongo L, Di Marzo V, and Maione S
- Subjects
- Animals, Male, Female, Mice, Hippocampus drug effects, Hippocampus metabolism, Mice, Inbred C57BL, Ethanolamines pharmacology, Ethanolamines metabolism, Dysbiosis, Amides pharmacology, Cognition drug effects, Disease Models, Animal, Gastrointestinal Microbiome drug effects, Cognitive Dysfunction drug therapy, Cognitive Dysfunction metabolism, Cognitive Dysfunction etiology, Vitamin D Deficiency complications, Vitamin D Deficiency drug therapy
- Abstract
There is a growing evidence suggesting the association of vitamin D deficiency (VDD) and cognitive impairment. In this study we evaluated the possible involvement of gut microbiota in the cognitive impairments mediated by VDD and investigated the effects of pharmacological treatment with the oxazoline derivative of the aliamide palmitoylethanolamide, 2-Pentadecyl-2-oxazoline (PEA-OXA). Mice were submitted to behavioural, biochemical and electrophysiological analysis to assess whether their vitamin D status affected cognitive performance together with gut microbiota composition. In VDD mice we found cognitive malfunctioning associated with reduced neuroplasticity, indicated by impaired long term potentiation, and neuroinflammation at the hippocampal level. Importantly, PEA-OXA counteracted the cognitive impairments and modified the biochemical and functional changes induced by VDD. Additionally, PEA-OXA treatment enhanced gut microbiota diversity, which tended to be decreased by VDD only in female mice, elevated the relative abundance of lactic and butyric acid-producing families, i.e. Aerococcaceae and Butyricicoccaceae, and reversed the VDD-induced decrease of butyrate-producing beneficial genera, such as Blautia in female mice, and Roseburia in male mice. These data provide novel insights for a better understanding of the cognitive decline induced by VDD and related gut dysbiosis and its potential therapeutic treatment., Competing Interests: Declaration of Competing Interest All the Authors declare that there is not conflict of interest., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
16. Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone.
- Author
-
Di Micco S, Ciaglia T, Salviati E, Michela P, Kostrzewa M, Musella S, Schiano Moriello A, Di Sarno V, Smaldone G, Di Matteo F, Capolupo I, Infantino R, Bifulco G, Pepe G, Sommella EM, Kumar P, Basilicata MG, Allarà M, Sánchez-Fernández N, Aso E, Gomez-Monterrey IM, Campiglia P, Ostacolo C, Maione S, Ligresti A, and Bertamino A
- Subjects
- Mice, Animals, Pyrroles pharmacology, Neurotransmitter Agents pharmacology, Scopolamine Derivatives, Cannabinoid Receptor Agonists pharmacology, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Cannabinoids pharmacology
- Abstract
The cannabinoid system is one of the most investigated neuromodulatory systems because of its involvement in multiple pathologies such as cancer, inflammation, and psychiatric diseases. Recently, the CB2 receptor has gained increased attention considering its crucial role in modulating neuroinflammation in several pathological conditions like neurodegenerative diseases. Here we describe the rational design of pyrrole-based analogues, which led to a potent and pharmacokinetically suitable CB2 full agonist particularly effective in improving cognitive functions in a scopolamine-induced amnesia murine model. Therefore, we extended our study by investigating the interconnection between CB2 activation and neurotransmission in this experimental paradigm. To this purpose, we performed a MALDI imaging analysis on mice brains, observing that the administration of our lead compound was able to revert the effect of scopolamine on different neurotransmitter tones, such as acetylcholine, serotonin, and GABA, shedding light on important networks not fully explored, so far., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
17. Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice.
- Author
-
Belardo C, Jebali J, Boccella S, Infantino R, Fusco A, Perrone M, Bonsale R, Manzo I, Iannotta M, Scuteri D, Ferraraccio F, Panarese I, Ferrara G, Guida F, Luongo L, Palazzo E, Srairi-Abid N, Marrakchi N, and Maione S
- Subjects
- Animals, Male, Mice, Cyclooxygenase 2 metabolism, Cytokines metabolism, Edema drug therapy, Edema chemically induced, Nitric Oxide Synthase Type II metabolism, Pain drug therapy, Pain chemically induced, Spinal Cord drug effects, Spinal Cord metabolism, Viper Venoms pharmacology, Viper Venoms therapeutic use, Formaldehyde, Inflammation chemically induced, Inflammation drug therapy, Lectins, C-Type therapeutic use
- Abstract
Background: Integrins, important extracellular matrix (ECM) receptor proteins, are affected by inflammation and can participate in the maintenance of many painful conditions. Although they are ubiquitous and changeable across all cell types, the roles of these cell adhesion molecules in pathological pain have not been fully explored., Objective: We evaluated the effects of the subcutaneous injection of lebecetin, a C-type lectin isolated from Macrovipera lebetina snake venom, previously reported to inhibit α5β1 and αv integrin activity, on different components of inflammation induced by the formalin administration in the hind paw of mice., Methods: The formalin-induced nocifensive behavior, edema, and histopathological changes in the hind paw associated with cytokine, iNOS, and COX2 expression, nociceptive-specific neuron activity, and microglial activation analysis in the spinal cord were evaluated in mice receiving vehicle or lebecetin pretreatment., Results: Lebecetin inhibited the nocifensive responses in the formalin test, related edema, and cell infiltration in the injected paw in a biphasic, hormetic-like, and dose-dependent way. According to that hormetic trend, a reduction in pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha and upregulation of the anti-inflammatory cytokine IL-10 in the spinal cord were found with the lowest doses of lebecetin. Moreover, COX2 and iNOS expression in serum and spinal cord followed the same biphasic pattern of cytokines. Finally, nociceptive neurons sensitization and activated microglia were normalized in the dorsal horn of the spinal cord by lebecetin., Conclusion: These findings implicate specific roles of integrins in inflammation and tonic pain, as well as in the related central nervous system sequelae., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
18. The long-term exercise after traumatic brain injury: Reharmonizing brain by sound body.
- Author
-
Bonsale R, Infantino R, Perrone M, Marabese I, Ricciardi F, Fusco A, Teweldemedhin MM, Boccella S, Guida F, and Rinaldi B
- Subjects
- Mice, Animals, Brain, Anxiety etiology, Brain Injuries psychology, Brain Concussion, Cognitive Dysfunction
- Abstract
Traumatic brain injuries (TBI) refer to multiple acquired dysfunctions arising from damage to the brain caused by an external force, including rapid acceleration/deceleration and concussion. Among them, mild TBI (mTBI) accounts for most cases (up to 90%) of injuries. It is responsible for a variety of symptoms, including anxiety, depression, and cognitive impairments that remain difficult to be treated. It has been reported that regular physical activity, as well as, improving life quality, display a neuroprotective function, suggesting a possible role in post-traumatic rehabilitation. In this study, we investigated the effects of treadmill exercise in a mice mTBI model by behavioural, electrophysiological and neurochemical analysis. Daily exercise decreased anxiety, aggressive behavior, and depression in mTBI mice. Accordingly, electrophysiological and neurochemical maladaptive rearrangement occurring in the hippocampus of mTBI mice were prevented by the exercise., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
19. Absolute quantification of myocardial uptake of 99m Tc-DPD in patients with cardiac amyloidosis due to transthyretin deposits (ATTR).
- Author
-
Sebastián Palacid F, Álvarez Mena N, Del Carmen Zambrano Infantino R, García Aragón M, Alonso Rodríguez M, Pérez López B, Gamazo Laherrán C, González Soto MJ, and Ruano Pérez R
- Subjects
- Humans, Organotechnetium Compounds, Heart diagnostic imaging, Myocardium, Prealbumin, Amyloidosis diagnostic imaging
- Abstract
Purpose: To determine the diagnostic contribution of the absolute quantification of the myocardial deposit of
99m Tc-DPD in patients with cardiac amyloidosis due to transthyretin deposits (ATTR)., Materials and Methods: SPECT/CT was performed in 41 patients with positive scintigraphic results for ATTR cardiac amyloidosis. The patients were divided into two groups (Perugini grades 2 and 3) and the SUVmax at the level of the bone and both ventricles and the percentage of dose calculated in these areas were calculated. The Student's t-test was used to compare results and the area under the curve (AUC) was calculated to assess differential efficacy and establish discriminatory cut-off points between both groups of patients., Results: Statistically significant differences were observed in all the study variables, with the exception of bone SUVmax . The differences with the greatest statistical power were observed in the variables SUVmaxRV and the percentage of dose in both ventricles (p < 0.001). The cut-off point obtained for the variable SUVmaxLV was 8.620 (sensitivity 87.9% and specificity 100%; AUC 0.966), while that of the variable SUVmaxRV was 6.195 (sensitivity 81.8% and specificity 100%; AUC 0.955)., Conclusions: The absolute quantification of myocardial uptake of99m Tc-DPD in the SPECT/CT images of patients with suspected cardiac amyloidosis due to transthyretin deposits represents a new diagnostic tool that allows adequate classification of patients according to the Perugini visual grading scale., (Copyright © 2023 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
20. Potential role of the hydroxyl carboxylic acid receptor type 2 (HCAR2) in microglia pathophysiology: A possible cross-talk with C-X-C chemokine receptor 1 (CXCR1).
- Author
-
Perrone M, Pagano M, Belardo C, Ricciardi F, Ricciardi F, Fusco A, Trotta MC, Infantino R, Gargano F, Parente A, Giacca R, Pieretti G, Luongo L, Maione S, Boccella S, and Guida F
- Subjects
- Rats, Animals, Lipopolysaccharides pharmacology, CX3C Chemokine Receptor 1 metabolism, Chemokine CX3CL1 metabolism, Receptors, Chemokine genetics, Receptors, Chemokine metabolism, Microglia, Chemokines, CXC metabolism, Chemokines, CXC pharmacology
- Abstract
Following insults or injury, microglia cells are activated contributing to the cytotoxic response or by promoting an immune-mediated damage resolution. Microglia cells express HCA2R, a hydroxy carboxylic acid (HCA) receptor, which has been shown to mediate neuroprotective and anti-inflammatory effects. In this study we found that HCAR2 expression levels were increased in cultured rat microglia cells after Lipopolysaccharide (LPS) exposure. In a similar fashion, the treatment with MK 1903, a potent full agonist of HCAR2, increased the receptor protein levels. Moreover, HCAR2 stimulation prevented i) cells viability ii) morphological activation iii) pro/anti-inflammatory mediators production in LPS-treated cells. Likewise, HCAR2 stimulation reduced the proinflammatory mediators mRNA expression induced by neuronal chemokine fractalkine (FKN), a neuronal derived chemokine activating its unique receptor, chemokine receptor 1 (CX3CR1) on microglia surface. Interestingly, electrophysiological recordings in vivo revealed that MK1903 was able to prevent the increase of the nociceptive neurons (NS) firing activity mediated by the spinal FKN application in healthy rats. Collectively, our data demonstrate that HCAR2 is functionally expressed in microglia, by showing its capability to shift microglia toward an anti-inflammatory phenotype. Moreover, we indicated the contribute of HCAR2 in the FKN signaling and suggested a possible HCAR2/CX3CR1 functional interaction. This study paves the way for further investigations aimed at understanding the role HCAR2 as potential target in neuroinflammation-based CNS disorders. This article is part of the Special Issue on "The receptor-receptor interaction as a new target for therapy"., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
21. Inhibition of anandamide breakdown reduces pain and restores LTP and monoamine levels in the rat hippocampus via the CB 1 receptor following osteoarthritis.
- Author
-
Kędziora M, Boccella S, Marabese I, Mlost J, Infantino R, Maione S, and Starowicz K
- Subjects
- Rats, Animals, Endocannabinoids, Serotonin, Dopamine, Hippocampus, Amines, Hyperalgesia, Chronic Pain, Osteoarthritis drug therapy
- Abstract
Chronic pain is a persistent, complex condition that contributes to impaired mood, anxiety and emotional problems. Osteoarthritis (OA) is one of the major causes of chronic pain in adults and elderly people. A substantial body of evidence demonstrate that hippocampal neural circuits, especially monoamine dopamine and serotonin levels, contributes to negative affect and avoidance motivation experienced during pain. Current pharmacological strategies for OA patients are unsatisfying and the endocannabinoid system modulation might represent an alternative for the treatment of OA-related pain. In the present study, we used a rat model of osteoarthritis induced by intra-articular injection of sodium monoiodoacetate to assess, 28 days post-induction, the contribution of endocannabinoid system on the possible alteration in pain perception and affective behavior, in LTP and monoamine levels in the lateral entorhinal cortex-dentate gyrus pathway. The results show that OA-related chronic pain induces working memory impairment and depressive-like behavior appearance, diminishes LTP, decreases dopamine levels and increases serotonin levels in the rat dentate gyrus. URB597 administration (i.p., 1 mg/kg) reduces hyperalgesia and mechanical allodynia, improves recognition memory and depressive-live behavior, restores LTP and normalizes monoamine levels in the hippocampus. The effect was observed 60-120 min post-treatment and was blocked by AM251, which proves the action of URB597 via the CB
1 receptor. Therefore, our study confirms the role of anandamide in OA-related chronic pain management at the behavioral and hippocampal levels. This article is part of the Special Issue on 'Advances in mechanisms and therapeutic targets relevant to pain'., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
22. Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice.
- Author
-
Guida F, Iannotta M, Misso G, Ricciardi F, Boccella S, Tirino V, Falco M, Desiderio V, Infantino R, Pieretti G, de Novellis V, Papaccio G, Luongo L, Caraglia M, and Maione S
- Subjects
- Animals, Disease Models, Animal, Hippocampus metabolism, Hyperalgesia metabolism, Long-Term Potentiation, Mice, Neuronal Plasticity, Neuralgia genetics, Neuralgia metabolism, Peripheral Nerve Injuries metabolism
- Abstract
Abstract: Neuropathic pain has long-term consequences in affective and cognitive disturbances, suggesting the involvement of supraspinal mechanisms. In this study, we used the spared nerve injury (SNI) model to characterize the development of sensory and aversive components of neuropathic pain and to determine their electrophysiological impact across prefrontal cortex and limbic regions. Moreover, we evaluated the regulation of several genes involved in immune response and inflammation triggered by SNI. We showed that SNI led to sensorial hypersensitivity (cold and mechanical stimuli) and depressive-like behavior lasting 12 months after nerve injury. Of interest, changes in nonemotional cognitive tasks (novel object recognition and Y maze) showed in 1-month SNI mice were not evident normal in the 12-month SNI animals. In vivo electrophysiology revealed an impaired long-term potentiation at prefrontal cortex-nucleus accumbens core pathway in both the 1-month and 12-month SNI mice. On the other hand, a reduced neural activity was recorded in the lateral entorhinal cortex-dentate gyrus pathway in the 1-month SNI mice, but not in the 12-month SNI mice. Finally, we observed the upregulation of specific genes involved in immune response in the hippocampus of 1-month SNI mice, but not in the 12-month SNI mice, suggesting a neuroinflammatory response that may contribute to the SNI phenotype. These data suggest that distinct brain circuits may drive the psychiatric components of neuropathic pain and pave the way for better investigation of the long-term consequences of peripheral nerve injury for which most of the available drugs are to date unsatisfactory., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.)
- Published
- 2022
- Full Text
- View/download PDF
23. Electronic structure and interfacial features of triphenylamine- and phenothiazine-based hole transport materials for methylammonium lead iodide perovskite solar cells.
- Author
-
Coppola C, Pecoraro A, Muñoz-García AB, Infantino R, Dessì A, Reginato G, Basosi R, Sinicropi A, and Pavone M
- Abstract
Recently, great research efforts have been devoted to perovskite solar cells (PSCs) leading to sunlight-to-power conversion efficiencies above 25%. However, several barriers still hinder the full deployment of these devices. Critical issues are related to PCE stability and device lifetimes, which could be improved by targeted engineering of the hole transport material (HTM). Indeed, the HTM is not only responsible for transporting holes and preventing direct contact between the photo-active perovskite and the charge collector layer, but it plays important structural and protective roles too. As alternatives to the widely used yet expensive and unstable Spiro-OMeTAD, organic HTMs based on triphenylamine (TPA) and phenothiazine (PTZ) moieties have been proposed. However, their performances in PSC devices, and in particular their interfacial properties with the most popular methylammonium lead iodide perovskite (MAPI) still need investigations to be fully determined. In this framework, here we report a first-principles study on the structural and the electronic properties of a recently designed TPA and PTZ-based HTM (HTM1) and its interface with the MAPI (001) surface, considering both the PbI
2 - and the MAI-terminations. We also addressed already known HTM molecular systems to allow for a direct comparison with the recently proposed HTM1: we characterized the molecular parameters and the MAPI/HTM interfacial properties for Spiro-OMeTAD, PTZ1, and PTZ2. Our results suggest that good adhesion properties do not ensure effective and efficient MAPI-HTM hole injection. Despite the theoretical good alignment between HTM1 HOMO and MAPI valence band edge, our results for the mutually polarized interface point out the lack of a sufficient driving force for hole transport. While the hole mobility of HTM1 outperforms those of the other HTM molecules, for this HTM molecule, our findings suggest the application of lead halide perovskite compositions other than MAPI, with substituents that lower its valence band maximum potential value.- Published
- 2022
- Full Text
- View/download PDF
24. PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation.
- Author
-
Belardo C, Alessio N, Pagano M, De Dominicis E, Infantino R, Perrone M, Iannotta M, Galderisi U, Rinaldi B, Scuteri D, Bagetta G, Palazzo E, Maione S, and Luongo L
- Subjects
- Adipose Tissue, Animals, Body Weight, Male, Mice, Obesity, Oxazoles, Weight Gain, Hyperalgesia drug therapy, Social Isolation
- Abstract
Chronic social isolation generates a persistent state of stress associated with obesity along with some neuro-endocrine disorders and central behavioral sequelae (eg anxiety, depression, aggression, and allodynia). In this study, we evaluated the effect of social isolation on body weight, depressive- and anxious-aggressive-like behavior, as well as on phenotypic changes of adipocytes from visceral adipose tissue of control (group-housed) or socially isolated (single-housed) male mice. The effect of treatment with pentadecyl-2-oxazoline (PEA-OXA), a natural alpha2 antagonist and histamine H3 protean partial agonist, on these alterations was also evaluated. Single or group-housed mice treated with vehicle or PEA-OXA underwent body weight, mechanical allodynia, anxious-, depressive- and aggressive-like behavior measurements. Proliferation rate, apoptosis, senescence, expression of fat lineage genes, lipid droplets and proinflammatory cytokines were measured on white adipose tissue adipocytes from group- or single-housed mice. Single housed mice developed weight gain, mechanical allodynia at the von Frey test, aggressiveness in the resident intruder test, depression- and anxiety-like behavior in the tail suspension and hole drop tests, respectively. Single housed mice receiving PEA-OXA showed a general resolution of both, physical-metabolic and behavioral alterations associated with social isolation. Furthermore, adipocytes from the adipose tissue of socially isolated mice showed an evident inflamed phenotype (i.e. a reduced rate of proliferation, apoptosis, senescence, and ROS hyper-production together with an increased expression of IL-1β, IL-10, IL-17, and TNF-α and a decrease of IL-6). The treatment with PEA-OXA on adipocytes from single housed mice produced a protective/anti-inflammatory phenotype with an increased expression of brown adipose tissue biomarker. This study confirms that persistent stress caused by social isolation predisposes to obesity and neuropsychiatric disorders. PEA-OXA, through its multi-target activity on alpha2 adrenoceptor and histamine H3 receptors, which have recently aroused great interest in the neuropsychiatric field, reduces weight gain, systemic pro-inflammatory state, allodynia, and affective disorders associated with social isolation., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
25. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia.
- Author
-
Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, and Maione S
- Subjects
- Animals, Brain-Derived Neurotrophic Factor metabolism, Depression etiology, Intracranial Hemorrhages complications, Mediator Complex Subunit 1 metabolism, Mice, Motor Activity physiology, Pain etiology, Rats, Sprague-Dawley, Receptor, trkB metabolism, Rats, Depression metabolism, Intracranial Hemorrhages metabolism, Microglia metabolism, Pain metabolism, Signal Transduction physiology, Thalamus metabolism
- Abstract
Central post-stroke pain (CPSP) and associated depression remain poorly understood and pharmacological treatments are unsatisfactory. Recently, microglia activation was suggested to be involved in CPSP pathophysiology. The goal of this study was to investigate the effectiveness of a co-ultramicronized combination of N-palmitoylethanolamide and luteolin (PEALut) in a mouse model of thalamic hemorrhage (TH)-induced CPSP. TH was established through the collagenase-IV injection in thalamic ventral-posterolateral-nucleus. PEALut effects in CPSP-associated behaviors were evaluated during a 28-days observation period. We found that repeated administrations of co-ultra PEALut significantly reduced mechanical hypersensitivity after TH, as compared to vehicle, by reducing the early microglial activation in the perilesional site. Moreover, PEALut prevented the development of depressive-like behavior (21 days post-TH). These effects were associated with the restoration of synaptic plasticity in LEC-DG pathway and monoamines levels found impaired in TH mice. Hippocampal MED1 and TrkB expressions were significantly increased in TH compared to sham mice 21 days post-TH, whereas BDNF levels were decreased. PEALut restored MED1/TrkB/BDNF expression in mice. Remarkably, we found significant overexpression of MED1 in the human autoptic brain specimens after stroke, indicating a translational potential of our findings. These results pave the way for better-investigating depression in TH- induced CPSP, together with the involvement of MED1/TrkB/BDNF pathway, proposing PEALut as an adjuvant treatment., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
26. Erythrocytes as a Model for Heavy Metal-Related Vascular Dysfunction: The Protective Effect of Dietary Components.
- Author
-
Notariale R, Infantino R, Palazzo E, and Manna C
- Subjects
- Animals, Blood Vessels metabolism, Cardiovascular Diseases etiology, Cardiovascular Diseases metabolism, Cardiovascular Diseases physiopathology, Cardiovascular System drug effects, Cardiovascular System metabolism, Cardiovascular System physiopathology, Disease Susceptibility, Endothelium drug effects, Endothelium metabolism, Environmental Pollutants adverse effects, Humans, Mercury toxicity, Oxidation-Reduction drug effects, Oxidative Stress drug effects, Blood Vessels drug effects, Blood Vessels physiopathology, Erythrocytes drug effects, Erythrocytes metabolism, Metals, Heavy toxicity
- Abstract
Heavy metals are toxic environmental pollutants associated with severe ecological and human health risks. Among them is mercury (Hg), widespread in air, soil, and water, due to its peculiar geo-biochemical cycle. The clinical consequences of Hg exposure include neurotoxicity and nephrotoxicity. Furthermore, increased risk for cardiovascular diseases is also reported due to a direct effect on cardiovascular tissues, including endothelial cells, recently identified as important targets for the harmful action of heavy metals. In this review, we will discuss the rationale for the potential use of erythrocytes as a surrogate model to study Hg-related toxicity on the cardiovascular system. The toxic effects of Hg on erythrocytes have been amply investigated in the last few years. Among the observed alterations, phosphatidylserine exposure has been proposed as an underlying mechanism responsible for Hg-induced increased proatherogenic and prothrombotic activity of these cells. Furthermore, following Hg-exposure, a decrease in NOS activity has also been reported, with consequent lowering of NO bioavailability, thus impairing endothelial function. An additional mechanism that may induce a decrease in NO availability is the generation of an oxidative microenvironment. Finally, considering that chronic Hg exposure mainly occurs through contaminated foods, the protective effect of dietary components is also discussed.
- Published
- 2021
- Full Text
- View/download PDF
27. Buprenorphine: Far Beyond the "Ceiling".
- Author
-
Infantino R, Mattia C, Locarini P, Pastore AL, Maione S, and Luongo L
- Subjects
- Humans, Analgesics pharmacokinetics, Analgesics therapeutic use, Buprenorphine pharmacokinetics, Buprenorphine therapeutic use, Chronic Pain drug therapy, Chronic Pain metabolism, Neuralgia drug therapy, Neuralgia metabolism, Quality of Life
- Abstract
Chronic pain, including neuropathic pain, represents an untreated disease with important repercussions on the quality of life and huge costs on the national health system. It is well known that opioids are the most powerful analgesic drugs, but they represent the second or third line in neuropathic pain, that remain difficult to manage. Moreover, these drugs show several side effects that limit their use. In addition, opioids possess addictive properties that are associated with misuse and drug abuse. Among available opioids compounds, buprenorphine has been suggested advantageous for a series of clinical reasons, including the effectiveness in neuropathic pain. Some properties are partly explained by its unique pharmacological characteristics. However, questions on the dynamic profile remain to be answered. Pharmacokinetics optimization strategies, and additional potentialities, are still to be explored. In this paper, we attempt to conceptualize the potential undiscovered dynamic profile of buprenorphine.
- Published
- 2021
- Full Text
- View/download PDF
28. Correction to: 2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors.
- Author
-
Boccella S, Guida F, Iannotta M, Iannotti FA, Infantino R, Ricciardi F, Cristiano C, Vitale RM, Amodeo P, Marabese I, Belardo C, de Novellis V, Paino S, Palazzo E, Calignano A, Di Marzo V, Maione S, and Luongo L
- Published
- 2021
- Full Text
- View/download PDF
29. Behavioral, Biochemical and Electrophysiological Changes in Spared Nerve Injury Model of Neuropathic Pain.
- Author
-
Guida F, De Gregorio D, Palazzo E, Ricciardi F, Boccella S, Belardo C, Iannotta M, Infantino R, Formato F, Marabese I, Luongo L, de Novellis V, and Maione S
- Subjects
- Animals, Brain metabolism, Brain pathology, Humans, Neuralgia metabolism, Neuralgia pathology, Pain Threshold, Peripheral Nerve Injuries metabolism, Peripheral Nerve Injuries pathology, Behavior, Animal physiology, Brain physiopathology, Disease Models, Animal, Electrophysiological Phenomena physiology, Neuralgia physiopathology, Peripheral Nerve Injuries physiopathology
- Abstract
Neuropathic pain is a pathological condition induced by a lesion or disease affecting the somatosensory system, with symptoms like allodynia and hyperalgesia. It has a multifaceted pathogenesis as it implicates several molecular signaling pathways involving peripheral and central nervous systems. Affective and cognitive dysfunctions have been reported as comorbidities of neuropathic pain states, supporting the notion that pain and mood disorders share some common pathogenetic mechanisms. The understanding of these pathophysiological mechanisms requires the development of animal models mimicking, as far as possible, clinical neuropathic pain symptoms. Among them, the Spared Nerve Injury (SNI) model has been largely characterized in terms of behavioral and functional alterations. This model is associated with changes in neuronal firing activity at spinal and supraspinal levels, and induces late neuropsychiatric disorders (such as anxious-like and depressive-like behaviors, and cognitive impairments) comparable to an advanced phase of neuropathy. The goal of this review is to summarize current findings in preclinical research, employing the SNI model as a tool for identifying pathophysiological mechanisms of neuropathic pain and testing pharmacological agent.
- Published
- 2020
- Full Text
- View/download PDF
30. Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions.
- Author
-
Boccella S, Iannotta M, Cristiano C, Iannotti FA, Bello FD, Guida F, Belardo C, Infantino R, Ricciardi F, Giannella M, Calignano A, Di Marzo V, Maione S, and Luongo L
- Abstract
Traumatic brain injury (TBI) represents an important public health problem and is followed by neuroinflammation and neurological dysfunctions. It has been suggested that brain trauma is often associated to deep behavioral alterations and chronic pain-like syndrome. Despite inducing minimal brain damage, mild TBI (mTBI) leads to persistent behavioral changes, including anxiety, depression, social interaction impairment, and aggressiveness. The clinical management of these symptoms is still unsatisfactory and new pharmacological treatments are needed, especially for the aggressiveness and depression. In a mouse model of mTBI, we investigated the effect of 2-Pentadecyl-2-Oxazoline (PEA-OXA), a natural compound, that is a secondary metabolite, found in green and roasted coffee beans, on both the pain perception, and neuropsychiatric dysfunctions. We found that the compound acts as a α2 adrenergic antagonist and this mechanism is here described for the first time. Mild TBI mice, starting from 14-d post-trauma, developed anxious and aggressive behavior, whilst depressive-like behavior and impaired social interactions were observed from the 60th d onward. PEA-OXA normalized all the behavioral changes investigated. We also investigated the memory impairments through Morris Water Maze (MWM) test. Both sham and mTBI mice treated with PEA-OXA showed amelioration in the reversal task of the MWM. Nevertheless, the main symptom of the long-term mTBI is represented by the depressive-like behavior, which was completely reversed by PEA-OXA repeated administration. In humans, mTBI-induced depression precedes the appearance of dementias and is characterized by a massive deficit of GABAergic transmission in the cortices. We found that PEA-OXA normalized the GABA changes in the prefrontal cortex. In order to prove the α2-mediated effect of the PEA-OXA we have performed open field test in naïve animals by microinjecting into the medial prefrontal cortex the dexomedetomidine, a selective α2 agonist with or without PEA-OXA co-injection. We found that PEA-OXA antagonized the α2 agonist effect on the locomotor activity. Moreover, PEA-OXA microinjection into the medial prefrontal cortex induced an enhancement of dopamine release. Collectively, these data suggest that this natural compound, through its multi-target activity is able to: i) ameliorate behavioral alterations (i.e. depression), ii) selectively normalize cortical GABA levels, iii) rescue the impaired neuronal activity in the prefrontal cortex., (Copyright © 2020 Boccella, Iannotta, Cristiano, Iannotti, Bello, Guida, Belardo, Infantino, Ricciardi, Giannella, Calignano, Di Marzo, Maione and Luongo.)
- Published
- 2020
- Full Text
- View/download PDF
31. Lighting the shades of hidden pain: a role for spinal cord neurons and microglia in vestibulodynia.
- Author
-
Infantino R, Gargano F, Boccella S, Belardo C, Morace AM, Guida F, Maione S, and Luongo L
- Published
- 2025
- Full Text
- View/download PDF
32. Facial diplegia as unusual variant of Guillain-Barré syndrome: first case reported in Venezuela.
- Author
-
Félix Piñerúa-Gonsálvez J, del Carmen Zambrano-Infantino R, Neomar Higuera S, Rodríguez C, and Calcaño C
- Subjects
- Adult, Humans, Male, Venezuela, Facial Paralysis diagnosis, Guillain-Barre Syndrome classification
- Abstract
The Guillain-Barré syndrome (GBS) is the most common cause of acute generalized paralysis. GBS is an acute inflammatory demyelinating polyradiculoneuropathy. It usually presents as a paralysis that starts in the lower limbs and then progresses symmetrically upward. The present study reports a case of bilateral facial palsy as the initial manifestation of GBS. This is a report of a case of a 37-year-old male, diabetic, that eight days after having suffered acute sinusitis, gradually presented with right hemicranial headache, dysarthria and sialorrhea. The neurological examination disclosed the absence of the bilateral frontal folds, accompanied by epiphora, bilateral lagophthalmos, bilateral Bell sign and salivary drooling through both commissures of lips. At 48 hours after hospital admission the patient showed paresis in both upper limbs. The cerebrospinal fluid analysis reported 1.1cells/mm3, fully represented by lymphocytes of normal aspect and total proteins were 196.9 mg/dL. The electromyography was consistent with acute demyelinating polyneuropathy, with a predominant motor component and a major facial involvement. With the clinical and laboratory findings, a diagnosis of GBS was established. Treatment was started with plasmapheresis and intravenous immunoglobulin, with the subsequent improvement of the clinic. The facial diplegia is part of the regional variants of GBS. Although about 60% of GBS patients present with facial weakness, it is usually preceded by weakness in the limbs. This case makes evident that GBS may present clinically as a facial diplegia.
- Published
- 2015
33. The debated problem of community-acquired pneumonia diagnosis: many guidelines, any guideline?
- Author
-
Infantino A and Infantino R
- Subjects
- Female, Humans, Male, Bronchitis diagnosis, Community-Acquired Infections therapy, General Practice statistics & numerical data, Pneumonia diagnosis, Pneumonia therapy, Practice Patterns, Physicians' statistics & numerical data, Primary Health Care statistics & numerical data
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.